Global mRNA Vaccines & Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024


    Table of Contents

      1 Market Overview

      • 1.1 mRNA Vaccines & Therapeutics Introduction
      • 1.2 Market Analysis by Type
        • 1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
        • 1.2.2 Individualized Cancer Treatment MRNA Vaccine
        • 1.2.3 Infectious Disease Treatment MRNA Vaccine
        • 1.2.4 Infection Prevention MRNA Vaccine
      • 1.3 Market Analysis by Applications
        • 1.3.1 Infectious Disease
        • 1.3.2 Cancer
        • 1.3.3 Other
      • 1.4 Market Analysis by Regions
        • 1.4.1 North America (United States, Canada and Mexico)
          • 1.4.1.1 United States Market States and Outlook (2014-2024)
          • 1.4.1.2 Canada Market States and Outlook (2014-2024)
          • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
        • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
          • 1.4.2.1 Germany Market States and Outlook (2014-2024)
          • 1.4.2.2 France Market States and Outlook (2014-2024)
          • 1.4.2.3 UK Market States and Outlook (2014-2024)
          • 1.4.2.4 Russia Market States and Outlook (2014-2024)
          • 1.4.2.5 Italy Market States and Outlook (2014-2024)
        • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
          • 1.4.3.1 China Market States and Outlook (2014-2024)
          • 1.4.3.2 Japan Market States and Outlook (2014-2024)
          • 1.4.3.3 Korea Market States and Outlook (2014-2024)
          • 1.4.3.4 India Market States and Outlook (2014-2024)
          • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        • 1.4.4 South America, Middle East and Africa
          • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
          • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
          • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
          • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
          • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force

      2 Manufacturers Profiles

      • 2.1 Moderna Therapeutics
        • 2.1.1 Business Overview
        • 2.1.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.1.2.1 Product A
          • 2.1.2.2 Product B
        • 2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.2 CureVac
        • 2.2.1 Business Overview
        • 2.2.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.2.2.1 Product A
          • 2.2.2.2 Product B
        • 2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.3 Translate Bio
        • 2.3.1 Business Overview
        • 2.3.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.3.2.1 Product A
          • 2.3.2.2 Product B
        • 2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.4 BioNTech
        • 2.4.1 Business Overview
        • 2.4.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.4.2.1 Product A
          • 2.4.2.2 Product B
        • 2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.5 Sangamo Therapeutics
        • 2.5.1 Business Overview
        • 2.5.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.5.2.1 Product A
          • 2.5.2.2 Product B
        • 2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.6 Argos Therapeutics
        • 2.6.1 Business Overview
        • 2.6.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.6.2.1 Product A
          • 2.6.2.2 Product B
        • 2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.7 In-Cell-Art
        • 2.7.1 Business Overview
        • 2.7.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.7.2.1 Product A
          • 2.7.2.2 Product B
        • 2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.8 eTheRNA
        • 2.8.1 Business Overview
        • 2.8.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.8.2.1 Product A
          • 2.8.2.2 Product B
        • 2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.9 Ethris
        • 2.9.1 Business Overview
        • 2.9.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.9.2.1 Product A
          • 2.9.2.2 Product B
        • 2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.10 Tiba Biotechnology
        • 2.10.1 Business Overview
        • 2.10.2 mRNA Vaccines & Therapeutics Type and Applications
          • 2.10.2.1 Product A
          • 2.10.2.2 Product B
        • 2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

      3 Global mRNA Vaccines & Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

      • 3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2017-2018)
      • 3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
      • 3.3 Market Concentration Rate
        • 3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018
        • 3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2018
      • 3.4 Market Competition Trend

      4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions

      • 4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
        • 4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2014-2019)
        • 4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2014-2019)
      • 4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      5 North America mRNA Vaccines & Therapeutics by Country

      • 5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
        • 5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)
        • 5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)
      • 5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      6 Europe mRNA Vaccines & Therapeutics by Country

      • 6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
        • 6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)
        • 6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)
      • 6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      7 Asia-Pacific mRNA Vaccines & Therapeutics by Country

      • 7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
        • 7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)
        • 7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)
      • 7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      8 South America mRNA Vaccines & Therapeutics by Country

      • 8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
        • 8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)
        • 8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)
      • 8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 8.4 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries

      • 9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
        • 9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2014-2019)
        • 9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2014-2019)
      • 9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 9.5 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)
      • 9.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2014-2019)

      10 Global mRNA Vaccines & Therapeutics Market Segment by Type

      • 10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
        • 10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2014-2019)
        • 10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2014-2019)
      • 10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price
        • 10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)
        • 10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2014-2019)
      • 10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
        • 10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)
        • 10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)
      • 10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
        • 10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)
        • 10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)
      • 10.5 Infection Prevention MRNA Vaccine Sales Growth and Price
        • 10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)
        • 10.5.2 Global Infection Prevention MRNA Vaccine Price (2014-2019)

      11 Global mRNA Vaccines & Therapeutics Market Segment by Application

      • 11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2014-2019)
      • 11.2 Infectious Disease Sales Growth (2014-2019)
      • 11.3 Cancer Sales Growth (2014-2019)
      • 11.4 Other Sales Growth (2014-2019)

      12 mRNA Vaccines & Therapeutics Market Forecast (2019-2024)

      • 12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2019-2024)
      • 12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2019-2024)
        • 12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)
        • 12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2019-2024)
        • 12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2019-2024)
        • 12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2019-2024)
        • 12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2019-2024)
      • 12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2019-2024)
        • 12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2019-2024)
        • 12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2019-2024)
      • 12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2019-2024)
        • 12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2019-2024)
        • 12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2019-2024)

      13 Sales Channel, Distributors, Traders and Dealers

      • 13.1 Sales Channel
        • 13.1.1 Direct Marketing
        • 13.1.2 Indirect Marketing
        • 13.1.3 Marketing Channel Future Trend
      • 13.2 Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        • 15.1 Methodology

        mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

        Scope of the Report:
        mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
        Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
        The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
        The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
        This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

        Market Segment by Manufacturers, this report covers
        Moderna Therapeutics
        CureVac
        Translate Bio
        BioNTech
        Sangamo Therapeutics
        Argos Therapeutics
        In-Cell-Art
        eTheRNA
        Ethris
        Tiba Biotechnology

        Market Segment by Regions, regional analysis covers
        North America (United States, Canada and Mexico)
        Europe (Germany, France, UK, Russia and Italy)
        Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        South America (Brazil, Argentina, Colombia etc.)
        Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

        Market Segment by Type, covers
        Standardization Of Cancer Treatment MRNA Vaccine
        Individualized Cancer Treatment MRNA Vaccine
        Infectious Disease Treatment MRNA Vaccine
        Infection Prevention MRNA Vaccine

        Market Segment by Applications, can be divided into
        Infectious Disease
        Cancer
        Other

        The content of the study subjects, includes a total of 15 chapters:
        Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
        Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics in 2017 and 2018.
        Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
        Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
        Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
        Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
        Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
        Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.



        Summary:
        mRNA Vaccines & Therapeutics Market Research Report is mRNA Vaccines & Therapeutics Market Report. Get mRNA Vaccines & Therapeutics market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on mRNA Vaccines & Therapeutics. mRNA Vaccines & Therapeutics Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED